Acquisition Completed

Quince Therapeutics acquisition of Orphai Therapeutics

Announced 18 May 2026

Advisers

Orphai Therapeutics

Target

Legal adviser

Quince Therapeutics

Acquirer

Financial adviser
Fairness opinion
Target
Orphai Therapeutics
Acquirer
Quince Therapeutics
Target based in
United States
Buyer based in
United States
Completed
18 May 2026
Sector
Biotech
Tags
Biotech, Pharma, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.